Presentation is loading. Please wait.

Presentation is loading. Please wait.

Vasopressin as Therapy During Nonocclusive Mesenteric Ischemia

Similar presentations


Presentation on theme: "Vasopressin as Therapy During Nonocclusive Mesenteric Ischemia"— Presentation transcript:

1 Vasopressin as Therapy During Nonocclusive Mesenteric Ischemia
Hagen Bomberg, MD, Heinrich V. Groesdonk, MD, Miriam Raffel, MD, Peter Minko, MD, Wolfram Schmied, Matthias Klingele, MD, Hans- Joachim Schäfers, MD  The Annals of Thoracic Surgery  Volume 102, Issue 3, Pages (September 2016) DOI: /j.athoracsur Copyright © 2016 The Society of Thoracic Surgeons Terms and Conditions

2 Fig 1 Survival of treated patients with nonocclusive mesenteric ischemia (Kaplan-Meier survival curves). The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2016 The Society of Thoracic Surgeons Terms and Conditions

3 Fig 2 Vasopressin concentrations. Comparison of postoperative serum vasopressin concentrations in the norepinephrine group (n = 37) versus the vasopressin group (n = 10). In 47 patients, samples were collected immediately before angiography and 24 and 48 hours after initiation of treatment for nonocclusive mesenteric ischemia. The horizontal line in the middle of each box indicates the median concentration of vasopressin, the cross inside the box is the mean value of vasopressin concentration, and the whiskers above and below the box mark the 95th and 5th percentiles, respectively. *p < versus vasopressin group. (NOMI = nonocclusive mesenteric ischemia.) The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2016 The Society of Thoracic Surgeons Terms and Conditions


Download ppt "Vasopressin as Therapy During Nonocclusive Mesenteric Ischemia"

Similar presentations


Ads by Google